Miss Elsa Silva
I3s (Institute for Research and Innovation in Health), Porto (Portugal)
Pharmacological Targeting of Senescence with ABT-263 in Experimental Heart Failure with Preserved Ejection Fraction
Event: Frontiers in CardioVascular Biomedicine 2022
Topic: Heart Failure
Session: Moderated poster 10 - Heart Failure
The senolyitc drug ABT-263 reverses HFpEF-associated inflammation, endothelial inflammation and fibrosis
Event: Heart Failure 2021
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2
ESC 365 is supported by
